Up-front use of aromatase inhibitors as adjuvant therapy for breast cancer: the emperor has no clothes

Affiliations

Bostjan Seruga et al. J Clin Oncol. 2009.

. 2009 Feb 20;27(6):840-2.

doi: 10.1200/JCO.2008.19.5594. Epub 2009 Jan 12.

¹ Division of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, Ontario, Canada.

No abstract available

Comment in

Aromatase inhibitors as adjuvant therapy for breast cancer.
Montemurro F, Aglietta M, Del Mastro L. Montemurro F, et al. J Clin Oncol. 2009 May 20;27(15):2566-7. doi: 10.1200/JCO.2009.22.2695. Epub 2009 Mar 30. J Clin Oncol. 2009. PMID: 19332706 No abstract available.
Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
Sánchez-Muñoz A, Ribelles N, Márquez A, Pérez-Ruiz E, Alba E. Sánchez-Muñoz A, et al. J Clin Oncol. 2009 Dec 10;27(35):e255-6; author reply e257-8. doi: 10.1200/JCO.2009.25.3914. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884520 No abstract available.